Health

By Harshit ATLANTA, NOV. 21—The U.S. Centers for Disease Control and Prevention (CDC) is facing intense national scrutiny after scientific information on its website was replaced with language that echoes long-debunked anti-vaccine talking points—statements suggesting that studies have not ruled out a possible link between childhood vaccines and autism. The shift has drawn sharp condemnation […]

By Harshit ATLANTA, NOV. 20 —Growing concerns over infant safety intensified this week as state officials revealed that ByHeart’s recalled baby formula is still being found on retail shelves across several states, even as laboratory tests confirmed contamination with Clostridium botulinum, the bacterium responsible for life-threatening infant botulism. More than 30 babies across the United

By Harshit MIAMI, NOVEMBER 19 — Breathing is one of the most automatic things we do, yet during exercise it becomes one of the most misunderstood and underused tools for strength, stability, and pain-free movement. Most people fixate on the mechanics of lifting weights, perfecting squat depth, or refining shoulder positioning — but the quiet

By HarshitWASHINGTON, November 18, 2025 — 10:45 PM EST Novo Nordisk, the maker of Wegovy and Ozempic, announced significant price cuts Monday for cash-paying customers — a move that reflects rising competitive pressure in the GLP-1 weight-loss market and direct intervention from the Trump administration. The reductions mark the latest effort by major drugmakers to

By HarshitNEW YORK, November 17, 2025 The global surge in the use of GLP-1 receptor agonists—including tirzepatide (Mounjaro), semaglutide (Ozempic, Wegovy), and liraglutide (Saxenda)—has reshaped obesity treatment, offering weight-loss results previously unseen in modern medicine.But as their popularity skyrockets, so do concerns about long-term safety, trial transparency, global equity, and the pharmaceutical influence behind most

By HarshitBoston, Massachusetts | November 16, 2025 | 01:55 AM EDT A major new study has found that a handful of simple lifestyle changes can lower the risk of heart disease by up to 40%, offering Americans a practical and powerful way to protect their long-term health. Published this week in the Journal of the

By HarshitBOSTON, November 15, 2025 — 10:45 PM EDT When Carol Saffran, 71, from the greater Boston area, began taking Ozempic last year to control her blood sugar, she didn’t expect her hair to thin. Prescribed the drug to prevent diabetes after a prediabetic diagnosis, she reached her ideal weight — but soon noticed an

By HarshitBoston, Massachusetts | November 14, 2025 | 10:45 PM EST Heart disease remains the leading cause of death in the United States, claiming more lives each year than cancer, accidents, and chronic respiratory illnesses combined. According to the Centers for Disease Control and Prevention (CDC), an American dies from cardiovascular disease every 34 seconds

By HarshitWASHINGTON, November 13, 2025 — 12:01 AM EST In a sweeping and precautionary move, ByHeart, a U.S.-based baby formula manufacturer, announced Tuesday that it is recalling all of its infant formula products nationwide following a multistate outbreak of infant botulism under investigation by the U.S. Food and Drug Administration (FDA) and the Centers for

By HarshitWASHINGTON, November 11, 2025 — 1:30 AM EDT In a landmark decision reshaping decades of women’s health policy, the U.S. Food and Drug Administration (FDA) announced Monday that it will remove the “black box” warning from many hormone treatments prescribed for menopause symptoms. The move, hailed by women’s health experts as long overdue, could